Floatz logo

Edoxaban

Extracranial Atherosclerosis

Asan Medical CenterSmall moleculeActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

18 Active assets in the Extracranial Atherosclerosis cohort.

Asset / SponsorPhaseRating
Acetylsalicylic Acid
Rajaie Cardiovascular Medical and Research Center
Phase 4BBB
SIMVASTATIN
Northern California Institute of Research and Education
Phase 4BBB
Lipitor
Erasmus Medical Center
Phase 4BB
ADVICOR COMPONENT NIACIN
University of Washington
Phase 4BB
Plavix
Ewha Womans University Seoul Hospital
Phase 4BB

View all 49 →

Same molecule, other indications

Edoxaban is also rated in:

atrial fibrillationDormant
A
Indicative ·
83 / 100
View asset →
intracerebral hemorrhageDormant
BBB
Indicative ·
78 / 100
View asset →
EmbolismDormant
BBB
Indicative ·
75 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →